Baker Avenue Asset Management, LP Abbott Laboratories Transaction History

Baker Avenue Asset Management, LP

$3.21 Billion
Q1 2025

A detailed history of Baker Avenue Asset Management, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 10,188 shares of ABT stock, worth $1.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,188

Previous 8,580 18.74%

Holding current value

$1.36 Million

Previous $970,000 39.28%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$111.1 - $140.22 $178,648 - $225,473	1,608 Added 18.74%	10,188 $1.35 Million
Q4 2024 Feb 14, 2025	BUY	$111.93 - $119.39 $142,486 - $151,983	1,273 Added 17.42%	8,580 $970,000
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $372,660 - $439,916	3,724 Added 103.94%	7,307 $833,000
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $141,626 - $158,090	1,406 Added 64.58%	3,583 $372,000
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $56,512 - $62,415	-516 Reduced 19.16%	2,177 $247,000
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $50,506 - $61,824	560 Added 26.25%	2,693 $296,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $84,161 - $100,980	-881 Reduced 29.23%	2,133 $206,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $249,329 - $277,805	-2,474 Reduced 45.08%	3,014 $328,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $987,778 - $1.16 Million	-10,198 Reduced 65.01%	5,488 $555,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $910,104 - $1.07 Million	-9,574 Reduced 37.9%	15,686 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2.44 Million - $2.83 Million	25,260 New	25,260 $2.44 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $3.7 Million - $4.52 Million	-32,485 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $3.75 Million - $4.6 Million	32,485 New	32,485 $4.57 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $214,724 - $239,039	-2,735 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $437 - $510	6 Added 0.22%	2,735 $230,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $107,475 - $129,937	-1,623 Reduced 37.29%	2,729 $218,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $84,637 - $95,882	1,291 Added 42.18%	4,352 $315,000
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $38,735 - $46,730	-637 Reduced 17.23%	3,061 $225,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $212,893 - $234,970	3,698 New	3,698 $226,000

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Account

Baker Avenue Asset Management, LP Abbott Laboratories Transaction History